Results 41 to 50 of about 101,889 (202)
5-aminosalicylate (5-ASA) agents remain the mainstay treatment in ulcerative colitis (UC). A number of oral 5-ASA agents are commercially available, including azobond pro-drugs, as well as delayed- and controlled-release forms of mesalazine.
Lakatos, Péter László
core +1 more source
Mycophenolate mofetil combined with steroids: New experiences in the treatment of idiopathic retroperitoneal fibrosis [PDF]
Background/Aim. Idiopathic retroperitoneal fibrosis (IRF) is an uncommon disease characterized by a retroperitoneal fibrotic tissue that often involve the ureters, leading to the obstructive nephropathy and variable impairment of renal function. Findings
Obrenčević Katarina +5 more
doaj +1 more source
Hashimoto's encephalopathy: A long-lasting remission induced by intravenous immunoglobulins [PDF]
Background. Hashimoto's encephalopathy (HE) is a rare autoimmune syndrome characterized by various neuropsychiatric manifestations, responsive to steroid treatment and associated with Hashimoto's thyroiditis.
Drulović Jelena +3 more
doaj +1 more source
Depressive symptoms among patients with schizophrenia in acute and remission phases [PDF]
Bacground/Aim. Researchers suggest that among people with schizophrenia, the prevalence of depressive symptoms ranges from 7% to 80%. The rate of depressive symptoms among people with schizophrenia varies widely because of the phase of the disease, type ...
Peljto Amir +3 more
doaj +1 more source
Favorable subset of acute myeloid leukemia with translocation 8;21: An elusive experience
Background: Risk stratification is critical in the management of acute myeloid leukemia (AML) and among the favorable subset translocations known, 8;21 seems elusive in our clinical practice as regards the response remission status. This led us to review
Nusrat Bashir Khan +5 more
doaj +1 more source
Background Subjective residual symptoms persist after clinical remission of rheumatoid arthritis (RA) in Japanese patients. Few studies have examined the relationship between these symptoms and subclinical inflammation using high‐sensitivity imaging ...
Masao Nawata +6 more
doaj +1 more source
Aminosalicylates for induction of remission or response in Crohn's disease [PDF]
Randomized trials investigating the efficacy of aminosalicylates for the treatment of mildly to moderately active Crohn's disease have yielded conflicting results. A systematic review was conducted to critically examine current available data on the efficacy of sulfasalazine and mesalamine for inducing remission or clinical response in these patients ...
Wee-Chian, Lim +3 more
openaire +2 more sources
Rituximab (RTX) has been reported to effectively maintain remission in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV). In this multicenter study involving 57 patients who achieved remission after 24 weeks, we evaluated the effectiveness
Chie Ogita +34 more
doaj +1 more source
The international acute lymphoblastic leukemia (ALL) study was designed to prospectively define the optimal therapy for adults 60 years of age or younger with newly diagnosed ALL.
Burnett, Alan Kenneth +41 more
core +1 more source
Role of the intensive care in treatment of patients with acute myeloid leukemia
Aim. Remission induction can be associate, with the life threatening complications and transfer to ICU of de novo acute myeloid leukemia (AML) patients (pts).
A V Bazhenov +11 more
doaj +1 more source

